Biotech companies presented at this year's Annual Meeting of the American Society of Clinical Oncology. Find out the latest ...

Digital business cards. Gilead’s virtual reality ride. Soccer’s Champions League final. A motorcycle brigade. | Digital ...

Exciting but early data about CAR-T against solid tumors, another strong showing by AstraZeneca, and an increase of cancer ...

Armaghani, MD, highlights two key presentations. First, a retrospective study on adjuvant endocrine therapy in ER-low breast ...

Get a preview of STAT's coverage for #ASCO2024, from events to a pop-up newsletter to the buzziest abstracts that will be ...

Germline variation does not predict the risk of taxane-induced peripheral neuropathy (TIPN) in Black women receiving ...

Sometimes getting a new drug to market is a relatively straight line, but sometimes it’s a winding road. GSK’s Blenrep ...

For patients with non-small cell lung cancer with the epidermal growth factor receptor (EGFR) variant, ivonescimab plus ...

An update on the disappointing ph2 study of KB-0742, highlighting potential efficacy and safety concerns, as well as future ...

Lynn Schuchter, MD, director of the Tara Miller Melanoma Center and Madlyn and Leonard Abramson Professor of Clinical ...

In total, 65 jobs are being created after logistics specialist ASCO secured a contract to work on Teesworks' South Bank Heavy Lift Quay, where services will include quayside planning and scheduling, ...

At ASCO, Eli Lilly, Genfleet Therapeutics and InxMed all presented new clinical data on KRAS G12C inhibitors in non-small ...